At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Endometriosis and Uterine Fibroid Treatment Study

Clinical Trial Title: 
Study to evaluate the long-term treatment of a new oral GnRH antagonist that is being developed for the management of serve endometriosis and uterine fibroid associated pain.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Barbara Soltes, MD
Clinical Trial Protocol Description: 

The purpose of this study is to test the safety and effectiveness of different doses of the investigational study drug, compared to placebo in managing moderate to severe pain associated with endometriosis.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have a clinical diagnosis of endometriosis established by mean of documented laparoscopy or laparotomy.
  • Be willing to use 2 forms of non-hormonal contraception.
  • Be between 18 and 49 years old.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Women's Health
Contact Phone: 
(312) 563-2611
Contact Name: 
Stephanie Arroyo